Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 492

1.
2.

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.

Tang T, Glanville J, Hayden CJ, White D, Barth JH, Balen AH.

Hum Reprod. 2006 Jan;21(1):80-9. Epub 2005 Sep 30.

PMID:
16199429
3.

Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?

Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R.

Eur J Obstet Gynecol Reprod Biol. 2005 Dec 1;123(2):204-11.

PMID:
16316811
4.

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.

Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.

Fertil Steril. 2004 Oct;82(4):893-902.

PMID:
15482765
6.

An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome.

Karimzadeh MA, Javedani M.

Fertil Steril. 2010 Jun;94(1):216-20. doi: 10.1016/j.fertnstert.2009.02.078. Epub 2009 May 21.

PMID:
19463994
7.

Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis.

Nieuwenhuis-Ruifrok AE, Kuchenbecker WK, Hoek A, Middleton P, Norman RJ.

Hum Reprod Update. 2009 Jan-Feb;15(1):57-68. doi: 10.1093/humupd/dmn043. Epub 2008 Oct 15. Review.

PMID:
18927072
8.

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.

Gambineri A, Pelusi C, Genghini S, Morselli-Labate AM, Cacciari M, Pagotto U, Pasquali R.

Clin Endocrinol (Oxf). 2004 Feb;60(2):241-9.

PMID:
14725687
9.
10.

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

Lindholm A, Bixo M, Björn I, Wölner-Hanssen P, Eliasson M, Larsson A, Johnson O, Poromaa IS.

Fertil Steril. 2008 May;89(5):1221-8. Epub 2007 Jul 2.

PMID:
17603048
11.

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.

Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.

Fertil Steril. 2008 Apr;89(4):899-906. Epub 2007 Nov 5.

PMID:
17980364
12.

C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome.

Kjøtrød SB, Romundstad P, von Düring V, Sunde A, Carlsen SM.

Fertil Steril. 2008 Mar;89(3):635-41. Epub 2007 Jun 4.

PMID:
17548076
13.

[Effect of lifestyle adjustment, metformin and rosiglitazone in polycystic ovary syndrome].

Ma LK, Jin LN, Yu Q, Xu L.

Zhonghua Fu Chan Ke Za Zhi. 2007 May;42(5):294-7. Chinese.

PMID:
17673038
14.
15.

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.

Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.

Int J Obes (Lond). 2008 Apr;32(4):692-9. Epub 2007 Dec 11.

PMID:
18071341
16.

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.

Ghazeeri G, Kutteh WH, Bryer-Ash M, Haas D, Ke RW.

Fertil Steril. 2003 Mar;79(3):562-6.

PMID:
12620440
18.

Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.

Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L.

Fertil Steril. 2006 May;85(5):1448-51. Epub 2006 Mar 31.

PMID:
16579997
19.
20.

Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS.

Gerli S, Papaleo E, Ferrari A, Di Renzo GC.

Eur Rev Med Pharmacol Sci. 2007 Sep-Oct;11(5):347-54.

PMID:
18074942

Supplemental Content

Support Center